{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:29:07Z","timestamp":1793161747581,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022110","name":"bioM\u00e9rieux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00134-025-08014-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:11:06Z","timestamp":1752567066000},"page":"1417-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial"],"prefix":"10.1007","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct03452826","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-0288","authenticated-orcid":false,"given":"Guillaume","family":"Voiriot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Tuffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Chauvelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kada","family":"Klouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Rouz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekontso Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Boh\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Megarbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Carvelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Navellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gibot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Dequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dessajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Armand-Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Vandenesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Verdet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durand Zaleski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tabassome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Fartoukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MULTI-CAP collaborative trial group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi Fabiola Ngaleu","family":"Siaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Gibelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"de Montmollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Desnos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Bouadma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"de Montmollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Doman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Sonneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariza","family":"Lamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eczenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Courte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Piton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Jeannot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Provent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gainnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dauwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Jacquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Luc","family":"Baudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Tankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Jaur\u00e9guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"4","key":"8014_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D et al (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3(4):e202899","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8014_CR2","doi-asserted-by":"publisher","first-page":"1900057","DOI":"10.1183\/13993003.00057-2019","volume":"54","author":"BJ Webb","year":"2019","unstructured":"Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC (2019) Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J Juill 54(1):1900057","journal-title":"Eur Respir J Juill"},{"issue":"10280","key":"8014_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","volume":"397","author":"A Dinh","year":"2021","unstructured":"Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M et al (2021) Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet Lond Engl 397(10280):1195\u2013203","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"8014_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M et al (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 18(1):95\u2013107","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"8014_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16(7):819\u2013827","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"8014_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49(6):615\u2013632","journal-title":"Intensive Care Med"},{"issue":"6","key":"8014_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jinf.2022.09.003","volume":"85","author":"S Poole","year":"2022","unstructured":"Poole S, Tanner AR, Naidu VV, Borca F, Phan H, Saeed K et al (2022) Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial. J Infect 85(6):625\u2013633","journal-title":"J Infect"},{"issue":"3","key":"8014_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0830","volume":"7","author":"DL Markussen","year":"2024","unstructured":"Markussen DL, Serigstad S, Ritz C, Knoop ST, Ebbesen MH, Faurholt-Jepsen D et al (2024) Diagnostic stewardship in community-acquired pneumonia with syndromic molecular testing: a randomized clinical trial. JAMA Netw Open 7(3):e240830","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8014_CR9","first-page":"67","volume":"13","author":"A Verroken","year":"2024","unstructured":"Verroken A, Favresse J, Anantharajah A, Rodriguez-Villalobos H, Wittebole X, Laterre PF (2024) Optimized antibiotic management of critically Ill patients with severe pneumonia following multiplex polymerase chain reaction testing: a prospective clinical exploratory trial. Antibiot Basel Switz 13(1):67","journal-title":"Antibiot Basel Switz"},{"issue":"1","key":"8014_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13054-020-03114-y","volume":"24","author":"C Monard","year":"2020","unstructured":"Monard C, Pehlivan J, Auger G, Alviset S, Tran Dinh A, Duquaire P et al (2020) Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit Care Lond Engl 24(1):434","journal-title":"Crit Care Lond Engl"},{"issue":"9","key":"8014_CR11","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1164\/rccm.202102-0498ST","volume":"203","author":"SE Evans","year":"2021","unstructured":"Evans SE, Jennerich AL, Azar MM, Cao B, Crothers K, Dickson RP et al (2021) Nucleic acid-based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 203(9):1070\u201387","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"8014_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048187","volume":"11","author":"G Voiriot","year":"2021","unstructured":"Voiriot G, Fartoukh M, Durand-Zaleski I, Berard L, Rousseau A, Armand-Lefevre L et al (2021) Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units. BMJ Open 11(8):e048187","journal-title":"BMJ Open"},{"issue":"Suppl 6","key":"8014_CR13","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M et al (2011) Guidelines for the management of adult lower respiratory tract infections\u2013full version. Clin Microbiol Infect 17(Suppl 6):E1-59","journal-title":"Clin Microbiol Infect"},{"issue":"9713","key":"8014_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet Lond Engl 375(9713):463\u201374","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"8014_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/511640","volume":"44","author":"RE Polk","year":"2007","unstructured":"Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C (2007) Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 44(5):664\u201370","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8014_CR16","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/s41467-024-51547-8","volume":"15","author":"G Abelenda-Alonso","year":"2024","unstructured":"Abelenda-Alonso G, Calatayud L, Rombauts A, Meije Y, Oriol I, Sopena N et al (2024) Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial. Nat Commun 15(1):7098","journal-title":"Nat Commun"},{"issue":"21","key":"8014_CR17","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388(21):1931\u201341","journal-title":"N Engl J Med"},{"issue":"4","key":"8014_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1164\/rccm.201112-2240OC","volume":"186","author":"SH Choi","year":"2012","unstructured":"Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY et al (2012) Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 186(4):325\u201332","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"8014_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cill\u00f3niz","year":"2011","unstructured":"Cill\u00f3niz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarr\u00fas A et al (2011) Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax avr 66(4):340\u2013346","journal-title":"Thorax avr"},{"issue":"2","key":"8014_CR20","first-page":"00595","volume":"8","author":"A Salina","year":"2022","unstructured":"Salina A, Schumann DM, Franchetti L, Jahn K, Purkabiri K, M\u00fcller R et al (2022) Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study. ERJ Open Res avr 8(2):00595\u201302021","journal-title":"ERJ Open Res avr"},{"issue":"6","key":"8014_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cmi.2023.01.009","volume":"29","author":"M Fartoukh","year":"2023","unstructured":"Fartoukh M, Nseir S, M\u00e9garbane B, Cohen Y, Lafarge A, Contou D et al (2023) Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial. Clin Microbiol Infect 29(6):734\u201343","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"8014_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.00128-20","volume":"58","author":"CN Murphy","year":"2020","unstructured":"Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O et al (2020) Multicenter evaluation of the biofire filmarray pneumonia\/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol 58(7):10\u2013128","journal-title":"J Clin Microbiol"},{"issue":"10","key":"8014_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02831-23","volume":"12","author":"D Sivakumaran","year":"2024","unstructured":"Sivakumaran D, Jenum S, Markussen DL, Serigstad S, Srivastava A, Saghaug CS et al (2024) Protein and transcriptional biomarker profiling may inform treatment strategies in lower respiratory tract infections by indicating bacterial-viral differentiation. Microbiol Spectr 12(10):e0283123","journal-title":"Microbiol Spectr"},{"issue":"9","key":"8014_CR24","first-page":"1308","volume":"27","author":"N Gastli","year":"2021","unstructured":"Gastli N, Loubinoux J, Daragon M, Lavigne JP, Saint-Sardos P, Pailhori\u00e8s H et al (2021) Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 27(9):1308\u201314","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"9","key":"8014_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie AM, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M et al (2022) Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med sept 10(9):877\u2013887","journal-title":"Lancet Respir Med sept"},{"issue":"12","key":"8014_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00170-8","volume":"5","author":"A Virk","year":"2024","unstructured":"Virk A, Strasburg AP, Kies KD, Donadio AD, Mandrekar J, Harmsen WS et al (2024) Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial. Lancet Microbe 5(12):100928","journal-title":"Lancet Microbe"},{"issue":"11","key":"8014_CR27","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/infdis\/jiv252","volume":"212","author":"AR Branche","year":"2015","unstructured":"Branche AR, Walsh EE, Vargas R, Hulbert B, Formica MA, Baran A et al (2015) Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis 212(11):1692\u2013700","journal-title":"J Infect Dis"},{"issue":"3","key":"8014_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJMoa1802670","volume":"379","author":"DT Huang","year":"2018","unstructured":"Huang DT, Yealy DM, Filbin MR, Brown AM, Chang CH, Doi Y, ProACT Investigators et al (2018) Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med 379(3):236\u2013249","journal-title":"N Engl J Med"},{"issue":"2","key":"8014_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S2213-2600(19)30367-4","volume":"8","author":"TP Hellyer","year":"2020","unstructured":"Hellyer TP, McAuley DF, Walsh TS, Anderson N, Conway Morris A, Singh S et al (2020) Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. Lancet Respir Med 8(2):182\u2013191","journal-title":"Lancet Respir Med"},{"issue":"2","key":"8014_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","volume":"51","author":"VI Enne","year":"2025","unstructured":"Enne VI, Stirling S, Barber JA, High J, Russell C, Brealey D et al (2025) INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Med 51(2):272\u2013286","journal-title":"Intensive Care Med"},{"issue":"1","key":"8014_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R, M\u00fcller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174(1):84\u201393","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8014_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.chest.2018.12.029","volume":"155","author":"DJ Pepper","year":"2019","unstructured":"Pepper DJ, Sun J, Rhee C, Welsh J, Powers JH 3rd, Danner RL, Kadri SS (2019) Procalcitonin-guided antibiotic discontinuation and mortality in critically Ill adults: a systematic review and meta-analysis. Chest 155(6):1109\u20131118","journal-title":"Chest"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:41:47Z","timestamp":1757241707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8014"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08014-9","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laurence Armand-Lef\u00e8vre received consulting fees from Shionogi and Viatris, and honoraria for lectures from Advanz, Shionogi and Pfizer. In addition, she performed unpaid lectures for BioM\u00e9rieux and Qiagen. Julien Dessajan received honoraria for lectures from BioM\u00e9rieux. Isabelle Durand-Zaleski received consulting fees from Bristol Myers Squibb, MSD, Sanofi, Pfizer and Roche. Muriel Fartoukh reported research grants from BioM\u00e9rieux and personal fees from BioM\u00e9rieux, Pfizer, SOS Oxygene and Fisher and Paykel. Tabassome Simon reported support for research from BioM\u00e9rieux, research grants from Astra Zeneca, Bayer, Boehringer, Daiichi Sankyo, Ili-Lilly, GSK, Novartis and Sanofi, and honoraria for lectures from Servier and Novartis. In addition, she reported participation in Data Safety Monitoring Board for Ablative Solutions, Air Liquide, Astra Zeneca, Sanofi, Novartis and 4Living Biotech. Jean-Francois Timsit Simon reported support for research from BioM\u00e9rieux, and consulting fees from Advanz, Menarini, Pfizer and Merck. In addition, he reported honoraria for lectures from BioM\u00e9rieux, MundiPharma and Merck. Guillaume Voiriot reported research grants from BioM\u00e9rieux and SOS Oxygene, and support for attending meetings from Oxyvie. Francois Vandenesch reported been founder and shareholder of Weezion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}